Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.biopha.2021.111998 http://scihub22266oqcxt.onion/10.1016/j.biopha.2021.111998 34385103!8352581!34385103     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biomed+Pharmacother 2021 ; 142 (ä): 111998 Nephropedia Template TP {{tp|p=34385103|t=2021. The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule |pdf=|usr=}}{{34385103}} gab.com Text The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule JO: Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=34385103 #FOAvip Lianhua-Qingwen capsule (LQC) is a commonly used Traditional Chinese Medicine (TCM) in China and has 11 herb components. The main active ingredient can target specific molecules and perform many clinic treatment roles. LQC has been authorized by National Medical Products Administration (NMPA) of China to treat severe acute respiratory syndrome (SARS) in 2002-2003, type A influenza virus HIN1 pandemic in 2009, H7N9, H3N2 and coronavirus disease-19 (COVID19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in 2020. It is also widely used to treat common cold with wind-heat syndrome, chronic rhinosinusitis (CRS), amygdalitis and chronic obstructive pulmonary disease. This article summarizes the advanced research progress of LQC in clinical application, mechanisms and provides new clues in the clinical application of LQC. Twit Text FOAVip The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule ????Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=34385103 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34385103 #FOAvip English Wikipedia <ref>{{Cite pmid|34385103}}</ref> The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule #MMPMID34385103 Shen X; Yin F Biomed Pharmacother 2021[Oct]; 142 (ä): 111998 PMID34385103show ga Lianhua-Qingwen capsule (LQC) is a commonly used Traditional Chinese Medicine (TCM) in China and has 11 herb components. The main active ingredient can target specific molecules and perform many clinic treatment roles. LQC has been authorized by National Medical Products Administration (NMPA) of China to treat severe acute respiratory syndrome (SARS) in 2002-2003, type A influenza virus HIN1 pandemic in 2009, H7N9, H3N2 and coronavirus disease-19 (COVID19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in 2020. It is also widely used to treat common cold with wind-heat syndrome, chronic rhinosinusitis (CRS), amygdalitis and chronic obstructive pulmonary disease. This article summarizes the advanced research progress of LQC in clinical application, mechanisms and provides new clues in the clinical application of LQC. |*COVID-19 Drug Treatment[MESH] |Antiviral Agents/pharmacology[MESH] |Capsules[MESH] |Drugs, Chinese Herbal/*pharmacology[MESH] |Humans[MESH] |Medicine, Chinese Traditional/methods[MESH] |Pharmaceutical Research[MESH]The mechanisms and clinical application of Traditional Chinese Medicin(epmc).pdf DeepDyve Pubget Overpricing